Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging

Svetlana Bezukladova1, Jouni Tuisku1, Markus Matilainen1

  • 1From the Turku PET Centre (S.B., J.T., M. Matilainen, A.V., M.N., S.S., M.S., M. Mohammadian, V.S., S.L., J.R., J.O.R., E.R., L.A.), University of Turku and Turku University Hospital; Division of Clinical Neurosciences (A.V., M.N., S.S., M.S., S.L., E.R., L.A.), Turku University Hospital; and Department of Medical Physics (V.S.), Division of Medical Imaging, Turku University Hospital, Finland.

Abstract

Insights

Microglial activation and white matter damage in multiple sclerosis (MS) brains are linked. This neuroinflammation and structural disruption correlate with increased clinical disability in MS patients.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Multiple Sclerosis (MS) is characterized by neuroinflammation and white matter (WM) damage.
  • Current imaging techniques may not fully capture the extent of MS pathology in normal-appearing white matter (NAWM).

Purpose of the Study:

  • To investigate the in vivo co-occurrence of microglial activation and microstructural WM damage in MS.
  • To determine the association between these pathologies and clinical disability.

Main Methods:

  • Positron Emission Tomography (PET) with [11C](R)-PK11195 to assess microglial activation (TSPO binding).
  • Diffusion Tensor Imaging (DTI) to evaluate white matter microstructure (FA, MD, RD).
  • Conventional MRI (cMRI) and clinical disability assessment (EDSS) in 55 MS patients and 15 healthy controls (HCs).

Main Results:

  • MS patients showed significant microstructural damage in NAWM compared to HCs (decreased FA, increased MD and RD).
  • Increased TSPO binding in NAWM correlated with DTI-derived WM abnormalities.
  • Both compromised WM integrity and microglial activation in NAWM were significantly associated with higher clinical disability (EDSS scores).

Conclusions:

  • Widespread structural disruption and neuroinflammation in NAWM are linked in MS.
  • These in vivo findings highlight the association between MS pathology and clinical disability.
  • Multimodal PET and DTI imaging offer valuable insights into MS pathology beyond conventional MRI.